Cardiovascular considerations of attention deficit hyperactivity disorder medications: a report of the European Network on Hyperactivity Disorders work group, European Attention Deficit Hyperactivity Disorder Guidelines Group on attention deficit hy (Q84575716)
Jump to navigation
Jump to search
scientific article published on 19 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cardiovascular considerations of attention deficit hyperactivity disorder medications: a report of the European Network on Hyperactivity Disorders work group, European Attention Deficit Hyperactivity Disorder Guidelines Group on attention deficit hy |
scientific article published on 19 July 2011 |
Statements
Cardiovascular considerations of attention deficit hyperactivity disorder medications: a report of the European Network on Hyperactivity Disorders work group, European Attention Deficit Hyperactivity Disorder Guidelines Group on attention deficit hyperactivity disorder drug safety meeting (English)
Robert M Hamilton
Eric Rosenthal
Martin Hulpke-Wette
John G I Graham
Joseph Sergeant
European Network of Hyperkinetic Disorders